SELLAS Life Sciences SLS
NASDAQ SLS
$11.33 -0.98 (-7.96%)
At close: Oct 1, 2026 · 4:00 PM EDT

SELLAS Life Sciences (SLS) Long-Term Debt Issuances (2016 - 2017)

Updated

SELLAS Life Sciences (SLS) recorded Long-Term Debt Issuances of -$4.45 million in Q2 2017, compared with $23.64 million a year earlier.

Analysis

SELLAS Life Sciences (SLS) Long-Term Debt Issuances (2016 - 2017) Analysis & Trends

For FY2016, SELLAS Life Sciences reported Long-Term Debt Issuances of $15 million.

  • Annual Long-Term Debt Issuances has a three-year compound annual growth rate of 15.0% (FY2013 to FY2016).
  • Across earlier years, Long-Term Debt Issuances came in at $9.87 million in FY2013.
  • Quarterly Long-Term Debt Issuances has ranged from -$8.64 million in Q4 2016 to $23.64 million in Q2 2016 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.98 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 SELLAS Life Sciences 2.49 Bn 2.49 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 -4.45 Mn
Mar 31, 2017 4.45 Mn
Dec 31, 2016 -8.64 Mn
Jun 30, 2016 23.64 Mn
API Access

SELLAS Life Sciences Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=SLS&period=max&api_key=YOUR_API_KEY